N04.4
Nephrotic syndrome with diffuse endocapillary proliferative glomerulonephritis
Clinical Classification Guidelines
Medical Intelligence & Overview
Nephrotic syndrome with diffuse endocapillary proliferative glomerulonephritis is a kidney disorder characterized by significant protein loss in the urine, swelling, and other related symptoms. This condition involves inflammation and proliferation of cells within the glomeruli, which are tiny filters in the kidneys responsible for removing waste and excess fluids from the blood. When the glomeruli become inflamed and proliferative, they compromise the kidney's filtering ability, leading to various health issues. Understanding this condition helps patients recognize symptoms and seek appropriate medical care.
Causes & Symptoms
Clinical Causes: Infections such as streptococcal or viral infections that trigger immune responses affecting the kidneys. Autoimmune diseases like lupus erythematosus, which cause the immune system to attack kidney tissues. Certain drugs or toxins that can induce immune reactions damaging the glomeruli. Genetic predispositions that may increase risk of developing immune-related kidney conditions. Other secondary causes linked to systemic illnesses that involve immune complex deposition in the kidneys.
Key Symptoms: Swelling (edema), especially around the eyes, ankles, and abdomen. Foamy or frothy urine caused by excess protein loss. Unexpected weight gain due to fluid retention. Elevated blood pressure in some cases. Fatigue and general feeling of illness. Decreased urine output or dark-colored urine.
Diagnostic & Treatment
Diagnosis Path: Urinalysis: Detects high levels of protein and possible presence of blood in the urine. Blood tests: Evaluate kidney function, measure serum albumin, and identify abnormal immune markers. Kidney biopsy: A small tissue sample taken via a needle to examine under a microscope, identifying inflammation and proliferation in the glomeruli. Immunological testing: Checks for underlying autoimmune conditions or immune complex deposits. Imaging studies: Ultrasounds or other imaging techniques to assess kidney size and structure.
Treatment Protocols: Corticosteroids: To decrease inflammation and immune response within the kidneys. Immunosuppressive drugs: Such as cyclophosphamide or mycophenolate mofetil, to control immune activity. Blood pressure medications: Including ACE inhibitors or angiotensin receptor blockers to protect kidney function and reduce proteinuria. Diuretics: To manage edema and excess fluid retention. Dietary adjustments: Lowering salt intake and maintaining a balanced diet to support overall health. Treating underlying infections or autoimmune conditions: Addressing root causes that contribute to kidney inflammation. Regular monitoring: Ongoing assessment of kidney function and protein levels in urine to guide treatment adjustments.
Clinical Advice & FAQs
Billing Guidance
Is N04.4 a billable ICD-10 code?
Yes, N04.4 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report N04.4?
Clinical documentation must specify the nature of Nephrotic syndrome with diffuse endocapillary proliferative glomerulonephritis and any associated comorbidities for accurate reporting.
Cite this Clinical Reference